Partitioning and localization of spin-labeled amantadine in lipid bilayers: An EPR study

Journal of Pharmaceutical Sciences

Volumn 87, Issue 10, 1998, Pages 1249-1254

  Subczynski, W K ^a   Wojas, J ^a   Pezeshk, V ^a   Pezeshk, A ^a  

^a MINNESOTA STATE UNIVERSITY MOORHEAD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; DIMYRISTOYLPHOSPHATIDYLCHOLINE; DISTEAROYLPHOSPHATIDYLCHOLINE; LIPOSOME; LIQUID PARAFFIN; ORGANIC SOLVENT; WATER;

ARTICLE; DRUG DISTRIBUTION; DRUG PENETRATION; DRUG SOLUBILITY; ELECTRON SPIN RESONANCE; LIPID BILAYER; PARTITION COEFFICIENT; SPIN LABELING; TEMPERATURE;

EID: 0031669384     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js970381n     Document Type: Article

References (50)

1. W.L. Davies R.R. Grunert R.F. Haft J.W. McGahen E.M. Neumayer M. Paulshock J.C. Watts T.R. Wood E.C. Herman C.E. Hoffman Antiviral activity of 1-ada-mantanamine (amantadine) Science 144 1964 862 863
2. R.W.H. Ruigrok E.M.A. Hirst A.J. Hay The specific inhibition of influenza A virus maturation by amantadine: an electron microscopic examination J. Gen. Virol. 72 1991 191 195
3. R.J. Sugrue G. Bahadur M.C. Zambon M. Hall-Smith A.R. Douglas A.J. Hay Specific structural alteration of the influenza hemagglutinin by amantadine EMBO J. 9 1990 3469 3476
4. R. Jackish T. Link B. Neufang R. Koch Studies on the mechanism of action of the antiparkinsonian drugs meman-tine and amantadine: no evidence for direct dopaminergic or antimuscarinic properties Arch. Int. Pharmakodyn. Ther. 320 1992 21 42
5. J.M. Rabey P. Nissipeanu A.D. Korczyn Efficacy of memantine, on NMDA receptor antagonist, in the treatment of Parkinson's disease J. Neural. Transm. Park. Dis. Dement. Sect. 4 1992 277 282
6. L.H. Pinto L.H. Holsinger R.A. Lamb Influenza virus M2 protein has ion channel activity Cell 69 1992 517 528
7. A.J. Hay The mechanism of action of amantadine and rimantadine against influenza viruses Notkins A.L. Oldstone M.B.A. Concepts in Viral Pathogeneses III 1989 Springer-Verlag New York 361 367
8. R.J. Sugrue A.J. Hay Structural characteristics of the M2 protein of influenza viruses: evidence that it forms a tetrameric channel Virology. 180 1991 617 624
9. O.P. Zhirnov Solubilization of matrix protein M1/M from virions occurs at different pH for orthomyxo-and paramyxo-viruses Virology 176 1990 274 279
10. R.A. Lamb The genes and proteins of influenza viruses Krug R.M. The Influenza Viruses 1989 Plenum Publishing Corp. New York 1 87
11. M. Marsh A. Helenius Virus entry into animal cells Adv. Virus Res. 36 1989 107 151
12. H.J. Freisleben G. Waltinger W. Schatton G. Zimmer Influences of Tromantadine and Nonoxinol 9 on the stability of red cell membrane Arzneim. Forsch/Drug Res. 39 1989 1202 1205
13. Y. Phonphok K.S. Rosenthal Stabilization of clathrin coated vesicles by amantadine, tromantadine and other hydrophobic amines FEBS Lett. 281 1991 188 190
14. J. Borman Memantine is a potent blocker of N-methyl-D-aspartate (NMDA) receptor channels Eur. J. Pharmacol. 166 1989 591 592
15. J. Kornhuber J. Borman W. Retz M. Hubers P. Riederer Memantine dosplaces [3H]MK-801 at therapeutic concentration in postmortem human frontal cortex Eur. J. Phar-macol. 166 1989 589 590
16. D. Moryl S. Danysz G. Quack Potential antidepresseve properties of amantadine, memantine and bifemelane Phar-macol. Toxicol. 72 1993 394 397
17. M. Weller F. Finiels-Marlier S.M. Paul NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine Brain. Res. 613 1993 143 148
18. A.T. Eldefrawi E.R. Miller D.L. Murphy M.E. Eldefrawi [3H] Phencyclidine interactions with the nicotinic acetylcholine receptor channel and its inhibition by psychotropic, antipsychotic, opiate, antidepressant, antibiotic, antiviral, and antiarrhythmic drugs Mol. Pharmacol. 22 1982 72 81
19. S. Eletr M.A. Williams T. Watkins A.D. Keith Perturbations of the dynamics of lipid alkyl chains in membrane systems: Effect on the activity of membrane-bound enzyme Biochim. Biophys. Acta 339 1974 190 201
20. M.K. Jain N. Yen-Min Wu T.K. Morgan Jr. M.S. Briggs R.K. Murray Jr. Phase transition in a lipid bilayer. II. Influence of adamantane derivatives Chem. Phys. Lipids. 17 1976 71 78
21. K.C. Duff A.J. Cudmore J.P. Bradshaw The location of amantadine hydrochloride and free base within phospholipid multilayers: a neutron and X-ray diffraction study Biochim. Biophys. Acta 1145 1993 149 156
22. J.S. Hyde W.K. Subczynski Spin-label oximetry Berliner L.J. Reuben J. Biological Magnetic Resonance 1989 Plenum Press New York 399 425
23. H. Lecuyer D.G. Derivichian Structure of aqueous mixtures of lecithin and cholesterol J. Mol. Biol. 45 1969 39 58
24. T. Higuchi S.S. Davis Thermodynamic analysis of structure-activity relationships of drugs: Prediction of optimal structure J. Pharm. Sci. 59 1970 1376 1383
25. N. Tsuzuki T. Hama T. Hibi R. Konishi S. Futaki K. Kitagawa Amantadine as a brain-directed drug carrier for poorly absorbed drug: Antinociseptive efffects of [D-Ala2]-Leu-Enkephalin derivatives conjugated with the 1-Adaman-tane moiety Biochem. Pharmacol. 41 1991 R5 R8
26. O.H. Griffith P.J. Dehlinger S.P. Van Shape of the hydrophobic barrier of phospholipid bilayers. Evidence for water penetration in biological membranes J. Membr. Biol. 15 1974 159 192
27. W.K. Subczynski A. Wisniewska J.J. Yin J.S. Hyde A. Kusumi Hydrophobic barrier of bilayer membrane formed by reduction of water penetration by alkyl chain unsaturation and cholesterol Biochemistry 33 1994 7670 7681
28. B.J. Gaffney C.M. McNamee Spin-label measurement of membranes. With appendix: a use of computers in EPR spectroscopy Fleisher S. Packer L. Methods in Enzymology 1974 Academic Press New York, S. Francisco, London 161 198
29. A. Pezeshk V. Pezeshk J. Wojas W.K. Subczynski Partitional and motional properties of a spin-labeled Dauno-mycin in lipid bilayers. An EPR study J. Inorg. Biochem. 46 1992 67 76
30. U.G. Eriksson T.N. Tozer G. Sosnovsky J. Lukszo R.C. Brasch Human erytrocyte membrane permeability and nitroxyl spin-label reduction J. Pharm. Sci. 75 1986 334 337
31. H.M. McConnell Molecular motion in biological membranes Berliner L.J. Spin Labeling, Theory and Application 1974 Academic Press New York 525 560
32. B.M. Sefton B.J. Gaffney Effects of the viral proteins on the fluidity of the membrane lipids in Sindbis virus J. Mol. Biol. 90 1974 343 358
33. N.F. Moore Y. Barenholtz R.R. Wagner Microviscosity of togavirus membranes studied by fluorescence depolarization: influence of envelope proteins and the host cell J. Virol. 19 1976 126 135
34. N. Greenberg S. Rottem Composition and molecular organization of lipids and proteins in the envelope of myco-plasmavirus MVL2 J. Virol. 32 1979 717 726
35. N. DeLuca A. Keith W. Snipes Studies with hydrophobic spin-labeled virucidal agent Antimicrob. Agents Chemother. 17 1980 63 70
36. F.R. Landsberger R.W. Compans P.W. Choppin J. Lenard Organization of the lipid phase in viral membranes. Effects of independent variation of the lipid and the protein composition Biochemistry 12 1973 4498 4502
37. Kawasaki, K.; Yin, J.J.; Subczynski, W.K.; Hyde, J.S.; Ohnishi, S.I.; Kusumi, A. Observation of lipid exchange reaction between two domains in the outer membrane of influenza virus by a pulse ESR spin labeling method. XIII International Conference on Magnetic Resonance in Biological Systems; Madison, WI, Aug 14-19, 1988; pp 13–31.
38. J. Cupp M. Klymkowski J. Sands A. Keith W. Snipes Effect of lipid alkyl chain perturbations on the asembly of baceriophage PM2 Biochim. Biophys. Acta 389 1975 345 375
39. J.J. Cheetham R.M. Epand Comparison of the interaction of the anti-viral chemotherapeutic agents amantadine and tromantadine with phospholipid membranes Biosci. Rep. 7 1987 225 230
40. E.G. Rozantsev Free Nitroxyl Radicals 1970 Plenum Press New York, London
41. N.M. Emanuel N.P. Konovalova R.F. Diatchkovskaya L.K. Denisova Nitroxyl derivatives of Rubomycin Antibi-otiki 27 1982 811 815
42. N.M. Emanuel N.P. Konovalova R.F. Diatchkovskaya Potential anticancer agents-nitroxyl derivatives of rubomy-cin Neoplasma 32 1985 285 292
43. T. Klenner M.R. Berger G. Sosnovsky N.U. Rao F. Winger D. Schmahl Evaluation of spin-labeled TEPA and CCNU analogues against osteosarcoma and MNU-induced mammary carcinoma of the SD-rat Arch. Geschwulstforsch. 59 4 1989 251 256
44. O.A. Shiryaeva M.A. Semenova L.A. Sibeldina S.A. Gon-charova N.P. Konovalova The study of phosphorous-containing metabolites in anthracycline resistant murine leukemia P388 cells Exp. Oncol. 11 1989 70 73
45. G. Sosnovsky N.U. Rao In the search for new anticancer drugs. XXII: Synthesis and anticancer evaluation of some dipeptides containing N-nitrosochloroethylamino and chlo-roethylamino moieties J. Pharm. Sci. 79 1990 369 370
46. A. Pezeshk V. Pezeshk Spectroscopic and biological studies of spin-labeled tetracycline Life Sci. 50 1992 1561 1565
47. N.M. Emanuel N.P. Konovalova Nitroxyl radicals for cancer chemotherapy Zhdanov R.I. Bioactive Spin Labels 1991 Springer-Verlag New York 439 460
48. A. Samuni C.M. Krishna P. Riesz E. Finkelstein A. Russo A novel metal free low molecular weight superoxide dismutase mimic J. Biol. Chem. 236 1988 17921 17924
49. J.B. Mitchel A. Samuni M.C. Krishna W.G. DeGraff M.S. Ahn U. Samuni A. Russo Biologically active metal-independent superoxide dismutase mimics Biochemistry 29 1990 2802 2807
50. A. Wisniewska A. Ligeza W.K. Subczynski Reoxidation of the reduced nitroxide radical spin label TEMPONE: involvment of oxygen and oxygen-derived active forms Curr. Top. Biophys. 16 1992 85 90